1 |
The World Health Organization (WHO). The World Health Report; 2003
|
2 |
World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva (Switzerland): World Health Organization Offset Publication No. 48; 1979
|
3 |
Miller AB, Hogestraeten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214
DOI
ScienceOn
|
4 |
Ahn SJ, Chung WK, Nah BS, Nam TK, Kim YC, Park KO. Outcomes after radiotherapy in inoperable patients with squamous cell lung cancer. J Korean Soc Ther Radiol Oncol 2001;19:216-223
과학기술학회마을
|
5 |
Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the pattern of failure in patients with unresectable non- oat cell carcinoma of the lung treated with definitive radiotherapy: report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-1881
DOI
ScienceOn
|
6 |
Chang SH, Lee KJ, Lee SN. The results of definitive radiation therapy and the analysis of prognostic factors for non-small cell lung cancer. J Korean Soc Ther Radiol Oncol 1998;16: 409-423
과학기술학회마을
|
7 |
Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;83:417-423
DOI
|
8 |
Perez CA, Stanly K, Rubin P, Kramer S, Brady LW, Marks JE. Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1980;6:987-994
DOI
ScienceOn
|
9 |
Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis. Cancer 1995;76:593-601
DOI
ScienceOn
|
10 |
Curran WJ, Scott C, Langer R, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 2003;22:2499
|
11 |
Ministry of Health and Welfare. 2002 Annual Report of the Korea Central Cancer Registry (Published in 2003)
|
12 |
Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990;323:940-945
DOI
ScienceOn
|
13 |
Sause W, Kolesar P, Taylor S IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000;117:358-364
DOI
ScienceOn
|
14 |
Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta- analysis. Ann Intern Med 1996;125:723-729
DOI
ScienceOn
|
15 |
Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524- 530
DOI
ScienceOn
|
16 |
Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-2699
DOI
|